Advertisement
U.S. markets close in 6 minutes

BeyondSpring Inc. (BYSI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.2000+0.0200 (+1.69%)
As of 03:44PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Short-term KST

Short-term KST

Previous Close1.1800
Open1.1000
Bid1.1900 x 3200
Ask1.2000 x 1800
Day's Range1.1000 - 1.2200
52 Week Range0.6530 - 2.0300
Volume96,896
Avg. Volume51,622
Market Cap46.819M
Beta (5Y Monthly)-0.14
PE Ratio (TTM)N/A
EPS (TTM)-0.7100
Earnings DateFeb 27, 2024 - Mar 02, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.25
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BYSI

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BeyondSpring, Inc.
    Daily – Vickers Top Buyers & Sellers for 02/21/2024The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
  • GlobeNewswire

    BeyondSpring Regains Compliance with Nasdaq Minimum Bid Price and Periodic Filing Requirements

    FLORHAM PARK, N.J., Feb. 26, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs, today announced that on February 20, 2024, the Company received a written notification on minimum bid price compliance (the “Notification Letter”)

  • GlobeNewswire

    BeyondSpring Receives Nasdaq Delinquency Notice Regarding Late Filing of Its Form 6-K

    NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs, today announced that on January 4, 2024, it received a Foreign Delinquency Compliance Plan Alert Letter (the “Letter”) from The Nasdaq Stock Market LLC (“Na

  • GlobeNewswire

    BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requirements

    NEW YORK, Dec. 18, 2023 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs, today announced that on December 14, 2023, it received a written notification from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in complia